Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
DBV-135 by DBV Technologies for Eosinophilic Esophagitis: Likelihood of Approval
DBV-135 is under clinical development by DBV Technologies and currently in Phase II for Eosinophilic Esophagitis. According to GlobalData, Phase...
Data Insights
DBV-135 by DBV Technologies for Milk Allergy: Likelihood of Approval
DBV-135 is under clinical development by DBV Technologies and currently in Phase II for Milk Allergy. According to GlobalData, Phase...